Virtual screening-led design of inhibitor scaffolds for the NLRP3 inflammasome
Bioorganic Chemistry · 2024-12 · 153 · 107909
DOI: 10.1016/j.bioorg.2024.107909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-12. Verfasst von Sherihan El-Sayed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Oxford Road, M13…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Drug Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation, Jordan University of Science and Technology, Ministry of Higher Education, Egypt.
Abstract (Originalsprache)
The NLRP3 inflammasome is a key target for drug discovery due to its implication in a range of inflammation-related diseases. In this work, we identify new inhibitors of the NLRP3 inflammasome via a hierarchical virtual screening strategy using molecular similarity, docking and MD simulation. The most potent inhibitors identified from a subsequent biological assay (IC50 of 1 - 4 μM) feature a sulfonamide group, a motif known to favour NLRP3 inhibition, in conjunction with an indole, benzofuran or tricyclic 6,7-dihydro-5H-indeno[5,6-b]furan ring, yielding novel scaffolds. These structures provide a basis for the design of more potent, selective NLRP3 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Oxford Road, M13 9PT, UK; Department of Medicinal Chemistry, Faculty of Pharmacy, Zaga…
- Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology,…
- Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Oxford Road, M13 9PT, UK; Department of Medicinal Chemistry and Pharmacognosy, Faculty…
- Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Oxford Road, M13 9PT, UK.
- Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Oxford Road, M13 9PT, UK. Electronic address: richard.bryce@manchester.ac.uk.
Förderung
- UK Research and Innovation
- Jordan University of Science and Technology
- Ministry of Higher Education, Egypt
- UK Research and Innovation Medical Research Council
Zitieren
APA
El-Sayed, S., McMahon, E., Musleh, S., Freeman, S., Brough, D., Kasher, P. R., & Bryce, R. A. (2024). Virtual screening-led design of inhibitor scaffolds for the NLRP3 inflammasome. Bioorganic Chemistry, 153, 107909. https://doi.org/10.1016/j.bioorg.2024.107909
Vancouver
El-Sayed S, McMahon E, Musleh S, Freeman S, Brough D, Kasher PR, et al. Virtual screening-led design of inhibitor scaffolds for the NLRP3 inflammasome. Bioorganic Chemistry. 2024;153:107909. doi:10.1016/j.bioorg.2024.107909
BibTeX
@article{ElSayed2024,
author = {El-Sayed, Sherihan and McMahon, Emily and Musleh, Sondos and Freeman, Sally and Brough, David and Kasher, Paul R and Bryce, Richard A},
title = {Virtual screening-led design of inhibitor scaffolds for the NLRP3 inflammasome},
journal = {Bioorganic Chemistry},
year = {2024},
volume = {153},
pages = {107909},
doi = {10.1016/j.bioorg.2024.107909}
}
EUVIMED